한국아스트라제네카 Astrazeneca Korea company information, Employees & Contact Information

AstraZeneca's Plumist, the world's first nasal spray-type influenza vaccine, has been released in Ko.. 매일경제

AstraZeneca says to invest $50 bil. in US The Korea Times

AstraZeneca Korea reapplies for Lynparza reimbursement in prostate cancer koreabiomed.com

AstraZeneca's rare disease arm in $1 billion deal for Pfizer gene therapies Reuters

AstraZeneca Stock Price Prediction: Is this Healthcare Giant Undervalued? TIKR.com

Lilly’s Jaypirca tipped to capture 60% of BTK leukemia market, leaving AstraZeneca, BeiGene in the dust Fierce Pharma

Alliance against lung cancer The Korea Times

AstraZeneca suspends supply of low-concentration Ultomiris in Korea koreabiomed.com

AstraZeneca’s Pipeline Is Deep, but Analysts Warn Growth May Normalize TIKR.com

AstraZeneca Korea appoints Chon Se-whan as Country President koreabiomed.com

Ipsen Korea appoints ex-AstraZeneca exec as new general manager koreabiomed.com

AstraZeneca's Imfinzi adds indication for adjuvant therapy before and after lung cancer surgery koreabiomed.com

AstraZeneca to pull anti-diabetes blockbuster Forxiga from Korea amid floods of generics koreabiomed.com

AstraZeneca to release highly concentrated formulation of orphan drug Ultomiris koreabiomed.com

AstraZeneca’s neurofibromatosis drug Koselugo gets insurance coverage koreabiomed.com

AstraZeneca’s Imjudo gets regulatory nod as 1st-line liver cancer treatment koreabiomed.com

AstraZeneca bets on genomic medicine koreabiomed.com

AstraZeneca Korea denies rumors on stopping price talks koreabiomed.com

SK chemicals, AstraZeneca seal global supply deal for diabetes combo koreabiomed.com

Regulator OKs type 2 diabetes combo co-developed by AstraZeneca, SK chemicals koreabiomed.com

AstraZeneca Korea elects Kim Sang-pyo as new CEO koreabiomed.com

Will AstraZeneca pull lung cancer drug off Korean market? koreabiomed.com

AstraZeneca to get new local partner for antidiabetic sale koreabiomed.com

AstraZeneca: Vaccine delivery talks with EU will go ahead The Korea Times

AstraZeneca, local firm fined over shady deal Yonhap News Agency

AstraZeneca Vaccine Rolls Out, Inoculations Begin at Hundreds of UK Hospitals 동아사이언스

AZ’s migraine drug Zomig in short supply due to hoarding koreabiomed.com

Gov't: People Under 30 to Get Non-AZ Vaccines; Plans Depend on Supply 동아사이언스

S. Korea to begin inoculating people aged 65 or over at nursing homes, hospitals this week Yonhap News Agency

'Disease Control Tower' Chief Jeong Eun-kyeong to Publicly Receive AstraZeneca Vaccine Tomorrow 동아사이언스

AstraZeneca, Pfizer, Moderna vaccines more than 80% effective against Delta variant 한겨레

Lung cancer therapy Tagrisso’s price cut by 96% koreabiomed.com

AstraZeneca Sells 7.7% Stake in Moderna for 1.4 Trillion Won 아시아경제

[Breaking] Prime Minister Jeong: "Pre-purchase Agreement Already Signed with AstraZeneca... Flexible Decision on Vaccine Vaccination Timing" 아시아경제

What are warning signs for rare blood clot syndrome after receiving COVID-19 vaccination? 한겨레

The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer, and Merck Illumina

[Exclusive] Military to Start Vaccinations This Month 아시아경제

[Photo] Lee Jeong-hoon, Gangdong-gu Mayor, Receives AstraZeneca Vaccine 아시아경제

US health agency questions AstraZeneca vaccine trial data Hull Daily Mail

AstraZeneca Jumps into the Oncology Subcutaneous Field with a $1.3B Deal with Alteogen 바이오스펙테이터

Lunit and AstraZeneca Announce First Results on AI-Driven EGFR Lung Cancer Validation 바이오스펙테이터

Alteogen, AstraZeneca Ink $1.9B Deal, Easing Patent Risks 팜이데일리

AstraZeneca Jumps into Lunit's AI Pathology Technology for EGFR Mutation Detection 바이오스펙테이터

Lunit and Agilent to co-develop AI companion diagnostics 바이오스펙테이터

Tagrisso Combo Sets OS Benchmark in EGFR+ Lung Cancer 히트뉴스

AZ Eyes Co-Development with Competitive Korean Biotechs 히트뉴스

Kwangdong Challenges AstraZeneca’s Tagrisso Patent 히트뉴스

AZ’s Farxiga Accepts PVA Price Adjustment Despite Korean Exit 히트뉴스

AZ Leads PNH Market as Samsung, Handok, Novartis Join Competition 히트뉴스